Application of PRP combined thread lifting with absorbable barbed PPDO threads in facial rejuvenation

  • Ju Tian
  • LiuHangHang Cheng
  • Xiao Cui
  • Min Xuan
  • Yu Yang
  • Zhifang Zheng
  • Biao Cheng
Cite this:
[1]
Ju Tian, “Application of PRP combined thread lifting with absorbable barbed PPDO threads in facial rejuvenation”, ijmhs, vol. 13, no. 04, pp. 2060–2068, Apr. 2023.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
91
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
   PDF  

Abstract

Background and Objective: Over the years, the use of platelet-rich plasma (PRP) and thread lifting in facial rejuvenation has become increasingly widespread.

However, it is still difficult to fully meet the expectations of patients and therapists using PRP alone or thread-lifting alone. The objective of this study was to observe the synergistic effect of PRP and thread lifting on facial rejuvenation.

Methods: Between January 2015 and September 2017, 30 patients (2 men and 28 women) were selected for this study. Combined use of PRP and thread-lifting with absorbable barbed poly(para-dioxanone)(PPDO) threads for facial rejuvenation. Efficacy and adverse effects were investigated by patients and physicians at the end of the treatment.

Results: 28 of the 30 participants completed the treatment and study and were followed up for 3–12 months. After a series of treatments, most of the participants achieved satisfactory results. The total subjective satisfaction scores assessed by the participants and physicians were 89.28% and 92.86%, respectively. No serious complications, such as allergies, severe swelling, hemorrhage, infection, or nerve damage, were found.

Conclusion: The combined use of PRP and thread lifting is a safe and effective method for facial rejuvenation, with a lower risk of complications.

Abbreviations: ECM = extracellular matrix, PPDO = poly(para-dioxanone), PRP = platelet-rich plasma.

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Section

Source

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”